Steven Cohen Corcept Therapeutics Inc Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 500,000 shares of CORT stock, worth $30.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$30.6 Million% of portfolio
0.06%Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
403Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.01 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$619 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$496 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$380 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$234 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.56B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...